Clinical Trials Logo

Clinical Trial Summary

Phthalates and bisphenols have been detected in a range of infant care products. This pilot study will test whether intervening on these sources of exposure during the critical period of minipuberty affects infants' body burden of phthalates and bisphenols. Investigators will recruit 10 participants from the ongoing NYU Children's Health and Development Study (CHES) cohort study who are >=37 weeks gestation, carrying a male fetus, and intending to breastfeed. Investigators will randomly assign them to use either conventional baby products or phthalate- and bisphenol-free baby products for the first three months of their children's lives. Toward the end of the intervention, investigators will collect maternal breast milk and infant urine, and assay samples for phthalate metabolite and bisphenol concentrations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05864209
Study type Interventional
Source NYU Langone Health
Contact
Status Completed
Phase N/A
Start date May 16, 2023
Completion date January 11, 2024

See also
  Status Clinical Trial Phase
Completed NCT05780047 - Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals in Adults of Child-Bearing Age N/A
Completed NCT04777929 - The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia